BSEBoard Meeting2d ago · 5 Aug 2026, 06:29 pm
(i) In compliance with Regulation 33 of the SEBI (LODR) Regulations, 2015, the unaudited standalone and consolidated financial results along with the limited review report, is attached ....
Sampre Nutritions Ltd · 530617
✦ AI SummaryResults
Sampre Nutritions Ltd has announced its unaudited financial results for the first quarter ended 30 June 2026, along with the approval of AGM notice and proposal to revise remuneration for Vishal Ratan Gurbani.
Analysis Scores
Earnings Impact6/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Sampre Nutritions Ltd - 530617 - Board Meeting Outcome for Audited Financial Results For The First Quarter Ended 30 June 2026, Approval Of AGM Notice, And Proposal To Revise Remuneration For Vishal Ratan Gurbani
Attachments (1)
📄pdf
Download →
090d9eac-9f4f-4e0c-8ccd-2330976002bc.pdf
View document text
SAMPRE NUTRITIONS LIMITED
CIN: L15499TG1991PLC013515
Date: 05 August 2026
BSE Limited
2nd Floor, New Trading Wing,
Rotunda Building, P.J. Towers,
Dalal Street, Fort,
Mumbai - 400001, MH
Subject: Outcome of the Board Meeting of the Company
Reference: BSE Symbol: SAMPRE; BSE Scrip Code: 530617
Sir / Madam,
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), and in reference to our letters
dated 31 July 2026, we wish to inform you that the Board of Directors of Sampre Nutritions Limited
(“the Company”) at their meeting held today i.e., 05 August 2026, have, inter-alia:
1. Approved the Notice of the Thirty-Fifth (35th) Annual General Meeting (“AGM”) of the
Company to be held on Friday, 04 September 2026, at 11:00 A.M. (IST), through Video
Conferencing (“VC”) / Other Audio-Visual Means (“OAVM”).
2. Approved the proposal to increase the remuneration for Vishal Ratan Gurbani (DIN: 07738685),
Whole-Time Director of the Company from INR 18,00,000 (Indian Rupees Eighteen Lakhs) only
per annum, to INR 60,00,000 (Indian Rupees Sixty Lakhs) only per annum with effect from 01
April 2026, subject to the approval of the members at the ensuing AGM of the Company.
We hereby inform you that the Board of Directors of the Company, at its meeting held on 05
August 2026, on the recommendation of the Nomination and Remuneration Committee, has
considered and approved the revision in the remuneration of Vishal Ratan Gurbani (DIN:
07738685), Whole-Time Director of the Company, from INR 18,00,000 (Indian Rupees Eighteen
Lakhs) only per annum to INR 60,00,000 (Indian Rupees Sixty Lakhs) only per annum with
effect from 01 April 2026, subject to the approval of the Members at the ensuing Annual General
Meeting of the Company. The aforesaid approval relates solely to the revision in remuneration
and does not constitute a fresh appointment or re-appointment of Vishal Ratan Gurbani as the
Whole-Time Director. All other terms and conditions of his existing appointment, as approved by
the Members, shall continue to remain unchanged.
3. Approved the standalone and consolidated unaudited financial results of the Company for the
first quarter ended 30 June 2026 for the financial year 2026-27.
Under Regulation 33 of the Listing Regulations, we enclose herewith a copy of the standalone
and consolidated unaudited financial results of the Company for the first quarter ended 30 June
2026 for the financial year 2026-27, accompanied by the limited review report(s) issued by the
statutory auditors of the Company.
Regd. Off & Works: Unit-1: Plot No. 133, I.E, Medchal - 501401, Telangana, India. Ph: +91-8418-222428
Unit-2: Plot No. 127, 128, Royes Building, I.E. Medchal, Malkajgiri - 501401.Telangana.
e-mail: gurbani@gurbanigroup.in, bkgurbani@gurbanigroup.in, www.gurbanigroup.in
Sampre Nutritions Limited
The Board Meeting commenced at 03:00 P.M. (IST) and concluded on 05:00 P.M. (IST).
The aforesaid information is also being hosted on the Company’s website at www.gurbanigroup.in.
Kindly take the above information on record and acknowledge the receipt of the same. Thanking you.
Sincerely,
For Sampre Nutritions Limited
Brahma Gurbani
Managing Director
(DIN: 00318180)
Enclosed: As above
SAMPRE NUTRITIONS LIMITED
SAMPRE NUTRITIONS LIMITED
CIN: L15499TG1991PLC013515
Plot No.133, Industrial Estate, Medchal, Telangana - 501401
Statement of Standalone Un-Audited Financial Results for the first quarter and three months ended 30th June 2026
< (In Lakhs)
Quarter ended Financial Year ended
Particulars 30.08.2026 31.03.2026 30.06.2026 31.03.2026 31.03.2025
Un-Audited Audited Un-Audited Audited Audited
1 [Revenue from operations 1,484.80] 1,509.83] 1,086.65 4,334.73) 2,512.42)
Il [Other income 6.73] 67.94 2,50} 71.03 37.45}
Il Total Revenue (I + 1) 1,491.53) 1,671.77] 1,089.15] 4,406.76) 2,549.87]
IV_|Exponses:
Cost of materials consumed 635.96] 621.41) 396.54) 1,491.00] 836.00)
[Purchases of Stack-in-Trade - E | ] 3
Changes in inventories of finished goods work-
in-progress and Stock-in-Trade ] ] i q ]
Employee benefits expense 509.93) 612,85 316.87] 1,337.03] 1,080.59)
Finance costs 25.69) 51.33) 30.81 136.78) 183.28]
Depreciation and amortizatjon expense 51.15 54.24) 39.26} 204.59) 197.03]
[Other expenses 188.92) 185.73 234.73 979.83) 969.15)
Total expenses 1,411.65 1.526.56) 1,018.21 4,149.23) 3,266.05]
Profit before exceptional and extraordinary
v itoms and tax (il - 1) 79.88 52.21 70.94) 256.53) (716.18))
VI_[Exceptional tems - E g E ]
VIl_|Profit before tax (V- Vi) 79.09) 5221 70.94 266.53 (716.18)
[Tax expense:
(2) Deferred tax E (130.02)] -} (130.02)) 14.74]
x__|Profit (Loss) for the period from continuing 7021 182,29 — e (73092)
operations (VII-Vill)
X | Profit/(loss) from discontinuing operations - - - -} -
XI_|Tax expense of discontinuing operations E ] ]
xi_|Profitiioss) from Discontinuing operations i i i i i
(after tax) (X-XI)
XI_[Profit (Loss) for the period (IX + X} 70.21] 182.23) 70.94) 336,66} (730.92)
XIV_|Other Comphrensive Income g 3 i 3] 1
- Items that will not be reclassified to profit or loss -} -} -] -] ]
~Tncome tax relating (o items that wil not be ] 3
reclassified to profit or loss ' ] §
~ltems that wil be reclassified to profit or 1055 - - E ] ]
~Income tax refating to items that will be reclassifisd
to profit or loss. 3 il Il ) |
XV Total comprehensive income for the period 70.21 182.23 70.94 386.55 (730.92)]
(X1+XIV)
[Earnings per equity share: (For confinuing operation)
XVl [(1) Basic 0.33 0.87 0.34 1.84 (3.48)|
(2) Diluted 0.50 129 0.50 273 5.17)
Earnings per equity share: (For discontinued operation)
XVIl - [{T} Basic ] = s = 5
(2) Diluted -l s - = -
Earnings per equity share: (For disconfinued & continuing operations)
XVl () Basic 0.3 0.87] 0.34] 1.84] (3.48)
(2) Diluted 0.50] 1.29] 0.50) 2.73| (5.17)}
The resuts have been prepared in accordanca with the India Accounting Stendards ('ind AS) as prescribed under Section 133 of the Companies Act, 2013 read wilh relevant
rules issued thereunder.
The atove results have been reviewed by the Audil Comiliee and thereafter approved by tha Board of Dircclors in their respective meetings held on 05th August, 2026,
These resuils have been subject to raview by the Stalutory Auditors.
The figures of the last quarler of previous year are balancing figures betwaen audited figures in respect of the fullfinancial year and the published figures for nine month ended
for provious year.
Figures of previous year have been regrouped wherever nacessary (o make them comparable.
For Sampre Nutritions Limited
Date: 05.08.2026
Placs : Medchal Brahma Géam
Managing Director
Regd. Off & Works : Unit-1: Plot No.133, I.E, Medchal - 501 401. Telangana, India.
Unit-2 : Plot No. 127,128, Royes Building, I.E, Medchal, R.R.Dist - 501 401. Telangana.
Ph : +91-8418-222428, 222429, Fax : +91-8418-222427
e-mail : gurbani@gurbanigroup.in, bkgurbani@gurbanigroup.in, www.gurbanigroup.com
N G RAO & ASSOCIATES eo e ieron
CHARTERED ACCOUNTANTS 98491 35573
INDIA 95421 87777
INDEPENDENT AUDITOR'S REVIEW REPORT ON REVIEW OF INTERIM STANDALONE
FINANCIAL RESULTS
TO THE BOARD OF DIRECTORS OF
Sampre Nutritions Limited
We have reviewed the accompanying Statement of Standalone Unaudited Financial Results of Sampre
Nutritions Limited ("the Company"), for the quarter ended June 30, 2026 ("the Statement"), being
submitted by the Company pursuant to the requirement of Regulation 33 and Regulation 52 of the SEBI
(Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ("the Listing
Regulations™)
This Statement, which is the responsibility of the Company's Management and approved by the Company's
Board of Directors, has been prepared in accordance with the recognition and measurement principles laid
down in the Indian Accounting Standard 34 "Interim Financial Reporting” ("Ind AS 34"), prescribed under
Section 133 of the Companies Act, 2013 read with
[Showing first 8,000 characters — download PDF for full document]